Hydralazine hydrochloride
SIGMA/H1753
Synonym: 1-
CAS Number: 304-20-1
Empirical Formula (Hill Notation): C8H8N4 · HCl
Molecular Weight: 196.64
EC Number: 206-151-0
MDL Number: MFCD00135998
Linear Formula: C8H8N4 · HCl
Product Type: Chemical
| assay | ≥99% (TLC) |
| biological source | synthetic (organic) |
| form | powder |
| InChI | 1S/C8H8N4.ClH/c9-11-8-7-4 |
| InChI key | SECXUXOCDLQOBI-MKFZHGHUSA |
| mp | 273 °C |
| Quality Level | 100 ![]() |
| SMILES string | Cl[H].NN=C1/N=NC=C2C=CC= |
| solubility | water: 50 mg/mL |
| Application: | Hydralazine hydrochloride has been used: • as a vasodilator to study its effects on hypertension in T-cell frequencies in juvenile rats • as a semicarbazide-sensitive amine oxidase (SSAO) inhibitor to study its effects on myocardial ischemia-reperfusion (I/R) injury • as a vasodilator to study its effects on insulin secretion and glucose tolerance |
| Biochem/physiol Actions: | Hydralazine hydrochloride has therapeutic effects against heart failure and high blood pressure. |
| Biochem/physiol Actions: | Inhibits DNA methyltransferase and modulates epigenetic regulation of gene expression. Non-selective MAO-A/B inhibitor; antihypertensive; semicarbazide-sensitive amine oxidase inhibitor. |
| Features and Benefits: | This compound is featured on the Dopamine and Norepinephrine Metabolism page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| Packaging: | 5, 10, 50 g in poly bottle |
| Symbol | GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H315 - H319 - H335 |
| Precautionary statements | P301 + P310 + P330 - P302 + P352 - P305 + P351 + P338 |
| Hazard Codes | Xn |
| Risk Statements | 22-36/37/38 |
| Safety Statements | 26-36/37/39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥99% (TLC) |
| mp | 273 °C |
| UNSPSC | 12352200 |


